Visipaque 270 mg I/ml, otopina za injekciju
| Name | Visipaque 270 mg I/ml, otopina za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-385628224 |
| Active Substance | jodiksanol |
| Composition | 1 ml otopine sadrži 550 mg jodiksanola što odgovara 270 mg joda |
| Pharmaceutical Form | otopina za injekciju |
| Manufacturer | GE Healthcare Ireland Limited, Carrigtwohill, Co. Cork, Irska GE Healthcare AS, Oslo, Norveška |
| Marketing Authorisation Holder | GE Healthcare AS, Nycoveien 1, Oslo, Norveška |
| Marketing Authorisation Date | 06.03.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/182 |
| Registration Number | 381-12-01/38-20-18 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | V08AB09 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
